366 Effects of rifampin, a strong metabolic enzyme inducer, on the pharmacokinetics (PK) of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), in patients with advanced solid tumors or lymphomas
Keyword(s):
Aurora A
◽
2015 ◽
Vol 53
(07)
◽
pp. 563-572
◽
Keyword(s):
2018 ◽
Vol 37
(4)
◽
pp. 666-673
◽
Keyword(s):
Keyword(s):